Universal Germline Testing in the Community

Description

This study seeks to enroll participants who have a diagnosis of a solid tumor cancer and are willing to undergo germline genetic testing for cancer risk. At baseline, patients will be asked to provide 2 types of blood samples: 1 tube for clinical genetic testing and 2 tubes for future research use. A tumor sample from a previous resection or biopsy will also be obtained and sent to the sponsor. The clinician will be asked to provide relevant medical history and demographic information to the sponsor in the form of electronic case report forms.

Conditions

Cancer, Solid Tumor, Solid Tumor, Adult

Study Overview

Study Details

Study overview

This study seeks to enroll participants who have a diagnosis of a solid tumor cancer and are willing to undergo germline genetic testing for cancer risk. At baseline, patients will be asked to provide 2 types of blood samples: 1 tube for clinical genetic testing and 2 tubes for future research use. A tumor sample from a previous resection or biopsy will also be obtained and sent to the sponsor. The clinician will be asked to provide relevant medical history and demographic information to the sponsor in the form of electronic case report forms.

Prospective Community Cancer Clinics-based Approach to Optimize Germline Testing in Cancer Patients in Rural Setting to Address Racial Disparities: UNIversal Germline Testing in the communitY (UNITY) Study

Universal Germline Testing in the Community

Condition
Cancer
Intervention / Treatment

-

Contacts and Locations

Rock Hill

Carolina Blood and Cancer Care Associates, PA', Rock Hill, South Carolina, United States, 29732

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patient has consented to germline genetic testing
  • * Patient has a histologically confirmed diagnosis of a solid tumor cancer
  • * Patient is willing to release previously collected tissue sample
  • * Patient is willing to provide research blood samples
  • * Patient must be at least 18 years of age
  • * Patient is unable to consent.
  • * Patient with hematologic malignancy

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Invitae Corporation,

Study Record Dates

2025-06-01